Clinical Management of Fibromyalgia
In the United States alone, 3 to 6 million people have fibromyalgia. Fibromyalgia is the most common cause of generalized pain in general medical practice. Primary care physicians and specialists are often uncomfortable making the diagnosis and uncertain how to proceed with a therapeutic plan. This handbook is timely, with the availability of newer pharmacologic choices for the treatment of fibromyalgia and related disorders. The majority of patients with fibromyalgia will be treated by primary care physicians and this handbook should be especially helpful to improve their skills in understanding, diagnosing, and treating this illness.
What people are saying - Write a review
We haven't found any reviews in the usual places.
What is Fibromyalgia?
1 Who Gets Fibromyalgia?
Diagnosis and Differential Diagnosis 2
1 Telltale Patient Descriptions of Fibromyalgia
2 Structured Interview for Fibromyalgia
1 Medically Unexplained Illnesses Concurrent
Associated Illnesses 3
1 Fibromyalgia and Mood Disorders
3 Demographic and Baseline Characteristics
8 Adverse Events in Pooled Trials
Clinical Trials in Fibromyalgia
10 Improvement in Average Pain Severity
6 Tricyclics in Fibromyalgia
Nonpharmacologic Management 7
1 The Nonpharmacologic Approach
6 EULAR Conclusions Regarding Nonmedicinal
7 Possible Etiologic Links Between
3 Alterations in Descending Analgesic Activity
7 Neuroendocrine Studies in Fibromyalgia
Pharmacologic Management 6
1 Rationale for the Use of Central Nervous
1 Pregabalin and Gabapentin
Comprehensive Management Plan 8
1 Patient and Family Education
5 Strategies to Achieve Improvement in Comorbid
Controversies in the Management of Fibromyalgia 9
3 Outcome and Disability in Fibromyalgia
5-HT2A receptor abnormalities acupuncture aerobic exercise algia amitriptyline analgesic Ann Rheum antidepressants Arnold LM Arthritis Res Ther Arthritis Rheum associated baseline brain chronic fatigue syndrome chronic pain chronic widespread pain Clauw DJ Clin Rheumatol clinical trials Cognitive behavioral therapy comorbid control over pain criteria Crofford LJ demonstrated diagnosis of FM disability disease dose double-blind drug Duloxetine effective efficacy EULAR evaluated evidence fibromy fibromyalgia patients fibromyalgia syndrome fibrositis fluoxetine FM patients FM symptoms functional illnesses Gabapentin Genetic Goldenberg DL headaches initial levels Management of Fibromyalgia Mease PJ medications mg/day Milnacipran mood disorders mood disturbances musculoskeletal myofascial pain nonpharmacologic treatment opioids pain score patients with fibromyalgia patients with FM pharmacologic Phase physical placebo placebo-controlled pramipexole pregabalin randomized receptor rheumatic rheumatologists Russell IJ significant improvement sleep disturbances somatization specialists SSRIs tender points tests tramadol treatment of fibromyalgia treatment of FM tricyclic Wolfe F